Press Releases

SOLCO HEALTHCARE U.S. ANNOUNCES THE APPROVAL OF GENERIC CYMBALTA® CAPSULES IN THE UNITED STATES

Aug 21, 2017 15:10

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Cymbalta® Capsules (Duloxetine delayed-release capsules), 20mg, 30mg...

Read more

SOLCO HEALTHCARE US, RECEIVES FDA APPROVAL FOR TELMISARTAN TABLETS, 20mg, 40mg and 80mg.

Jun 08, 2017 00:00

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Telmisartan tablets, 20mg, 40mg and 80mg, which are AB-rated equivalents to Micardis® by Boehringer Ingelheim. “This recent...

Read more

SOLCO HEALTHCARE INTRODUCES OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE Tablets

Apr 24, 2017 00:00

CRANBURY, NJ -- Solco Healthcare today announced the launch of generic version of Daiichi-Sankyo’s Benicar-HCT®, Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20mg/12.5mg, 40/12.5mg and 40mg/25mg.  Solco received its final approval by...

Read more

SOLCO HEALTHCARE US, INTRODUCES DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS, 150mg and 200mg

Nov 15, 2016 16:20

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Doxycycline Hyclate delayed-release tablets, 150mg and 200mg, which are AB-rated equivalents to Doryx® by Mayne Pharmaceutical. “This...

Read more

SOLCO HEALTHCARE U.S. ANNOUNCES THE APPROVAL OF GENERIC VFEND ® TABLETS IN THE UNITED STATES

Aug 12, 2016 10:59

CRANBURY, NJ – August 11, 2016 – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Vfend ® Tablets...

Read more

Solco News

Here you will find useful healthcare related information and latest industry news, including exclusive content available only on Solco News.


Archives

2017 2016